FR2393795B1 - Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique - Google Patents

Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique

Info

Publication number
FR2393795B1
FR2393795B1 FR7817167A FR7817167A FR2393795B1 FR 2393795 B1 FR2393795 B1 FR 2393795B1 FR 7817167 A FR7817167 A FR 7817167A FR 7817167 A FR7817167 A FR 7817167A FR 2393795 B1 FR2393795 B1 FR 2393795B1
Authority
FR
France
Prior art keywords
preparation process
therapeutic applications
carbostyryl derivatives
carbostyryl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7817167A
Other languages
English (en)
French (fr)
Other versions
FR2393795A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2393795A1 publication Critical patent/FR2393795A1/fr
Application granted granted Critical
Publication of FR2393795B1 publication Critical patent/FR2393795B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FR7817167A 1977-06-10 1978-06-08 Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique Expired FR2393795B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
FR2393795A1 FR2393795A1 (fr) 1979-01-05
FR2393795B1 true FR2393795B1 (fr) 1986-07-25

Family

ID=27284068

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817167A Expired FR2393795B1 (fr) 1977-06-10 1978-06-08 Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique

Country Status (21)

Country Link
US (1) US4298739A (cg-RX-API-DMAC7.html)
AR (2) AR224345A1 (cg-RX-API-DMAC7.html)
AT (1) AT367038B (cg-RX-API-DMAC7.html)
AU (1) AU510138B2 (cg-RX-API-DMAC7.html)
CA (1) CA1098907A (cg-RX-API-DMAC7.html)
CH (1) CH636087A5 (cg-RX-API-DMAC7.html)
DE (1) DE2825048A1 (cg-RX-API-DMAC7.html)
DK (1) DK149449C (cg-RX-API-DMAC7.html)
ES (2) ES470690A1 (cg-RX-API-DMAC7.html)
FI (1) FI69300C (cg-RX-API-DMAC7.html)
FR (1) FR2393795B1 (cg-RX-API-DMAC7.html)
GB (1) GB2002745B (cg-RX-API-DMAC7.html)
IE (1) IE46852B1 (cg-RX-API-DMAC7.html)
IT (1) IT1108326B (cg-RX-API-DMAC7.html)
MX (1) MX5527E (cg-RX-API-DMAC7.html)
NL (1) NL178074C (cg-RX-API-DMAC7.html)
NO (1) NO148813C (cg-RX-API-DMAC7.html)
NZ (1) NZ187452A (cg-RX-API-DMAC7.html)
PH (1) PH14670A (cg-RX-API-DMAC7.html)
PT (1) PT68157A (cg-RX-API-DMAC7.html)
SE (1) SE444562B (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
ES8607299A1 (es) * 1984-02-15 1986-06-01 Syntex Inc Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
TW201305B (cg-RX-API-DMAC7.html) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
KR930702307A (ko) * 1991-08-23 1993-09-08 오오쓰까 아끼히꼬 카르보스티릴 유도체 및 혈소판 응집 억제제
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法,組合物及套組
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2196453A1 (en) * 2008-12-10 2010-06-16 Cellvir Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
JP5649577B2 (ja) 2009-08-21 2015-01-07 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン−2,4−ジオン化合物の製造方法
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR102034748B1 (ko) 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP4424697A3 (en) 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
CA2920856A1 (en) 2013-08-09 2015-02-12 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (cg-RX-API-DMAC7.html) * 1972-12-14 1977-10-03
JPS5234629B2 (cg-RX-API-DMAC7.html) * 1973-02-03 1977-09-05
SE431451B (sv) * 1973-10-24 1984-02-06 Otsuka Pharma Co Ltd Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
US4298739A (en) 1981-11-03
AT367038B (de) 1982-05-25
IT1108326B (it) 1985-12-09
FI69300C (fi) 1986-01-10
DK149449B (da) 1986-06-16
DE2825048C2 (cg-RX-API-DMAC7.html) 1991-05-08
SE7806710L (sv) 1978-12-11
NZ187452A (en) 1980-05-27
FI781811A7 (fi) 1978-12-11
SE444562B (sv) 1986-04-21
MX5527E (es) 1983-09-23
AR224345A1 (es) 1981-11-30
CA1098907A (en) 1981-04-07
GB2002745A (en) 1979-02-28
CH636087A5 (de) 1983-05-13
NL7806245A (nl) 1978-12-12
NO782022L (no) 1978-12-12
PT68157A (en) 1978-07-01
IE781104L (en) 1978-12-10
AR225755A1 (es) 1982-04-30
NL178074C (nl) 1986-01-16
NO148813B (no) 1983-09-12
DE2825048A1 (de) 1978-12-14
IT7868355A0 (it) 1978-06-09
NO148813C (no) 1983-12-21
DK254878A (da) 1979-02-09
AU3686678A (en) 1979-12-13
AU510138B2 (en) 1980-06-12
FI69300B (fi) 1985-09-30
ES479138A1 (es) 1979-07-01
FR2393795A1 (fr) 1979-01-05
ATA421378A (de) 1981-10-15
DK149449C (da) 1986-11-24
IE46852B1 (en) 1983-10-05
GB2002745B (en) 1982-02-17
PH14670A (en) 1981-10-30
ES470690A1 (es) 1979-10-16

Similar Documents

Publication Publication Date Title
FR2393795B1 (fr) Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique
FR2383157B1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
BE867421A (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2387234B1 (fr) Derives de cephalosporine, leur procede de preparation et leurs applications en therapeutique
BE875174A (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leurs applications en therapeutique
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
BE878723A (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2532648B1 (fr) Derives de carbostyrile, leur procede de preparation et leur application en therapeutique
BE851893A (fr) Nouvelles aryl-3 oxazolidinones-2, leur procede de preparation et leur application en therapeutique
BE854268A (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
BE862785A (fr) Derives de pyrimido(6,1-a)isoquinoleine-2-one, leur procede de preparation et leur application en therapeutique
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE864312A (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
FR2315925A1 (fr) Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2313063A1 (fr) Derives de pyrrolotriazolopyrimidine leur procede de preparation et leurs applications en therapeutique
BE854133A (fr) 1,3-dihydro-heteroarylspito(isobenzofurannes)et leur procede de preparation et leur application therapeutique
BE866676A (fr) Derives de bisamidine, leur procede de preparation et leur application therapeutique
BE883713A (fr) Nouveau derives de carbostyrile, leur procede de preparation et leur application en therapeutique
FR2351965A1 (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
FR2353520A1 (fr) 1-aryloxy-2-hydroxy-3-aminopropanes, leur procede de preparation et leurs applications therapeutiques
BE882270A (fr) Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique
BE866928A (fr) Benzene-sulfonyl urees, leur procede de preparation et leur application therapeutique
BE868659A (fr) Nouveaux derives de benzamidine, leur procede de preparation et leurs applications en therapeutique
BE866648A (fr) Derives de triazolothiadiazines, leur procede de preparation et leurs applications en therapeutique
BE862878A (fr) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5,-tetrahydro-1h-3-benzazepines, leurs procede de preparation et application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse